12118 Federal Register / Vol. 76, No. 43 / Friday, March 4, 2011 / Notices 

anticipated that the draft report and 

recommendations, as revised in 

accordance with public comment and 

stakeholder input, will be presented to 

the NVAC for deliberation and decision 

for adoption in mid- or late 2011. 

DATES: To receive consideration, 

comments must be received no later 

than 5 p.m. EST on April 15, 2011. 

ADDRESSES: 

(1) The draft report and 

recommendations are available on the 

Web at http://www.hhs.gov/nvpo/nvac/ 

subgroups/adultimmunization. 

(2) By electronic mail, comments can 

be e-mailed to Lauren Wu, National 

Vaccine Program Office, at 

lauren.wu@hhs.gov. 

(3) By mail, comments can be 

submitted to: NVAC AIWG Report, c/o 

Lauren Wu, National Vaccine Program 

Office, 200 Independence Avenue, 

Room 715–H, Washington, DC 20201. 

FOR FURTHER INFORMATION CONTACT: 

Mark Grabowsky, National Vaccine 

Program Office, 200 Independence 

Avenue, Room 715–H, Washington, DC 

20201, Attn: NVAC Adult Immunization 

Working Group, Telephone (202) 260– 

2325; Fax: (202) 690–4631; E-mail: 

mark.grabowsky@hhs.gov. 

SUPPLEMENTARY INFORMATION: Over the 

past two decades, numerous reports and 

sets of recommendations to address the 

suboptimal immunization status of 

adults have been developed. These have 

been issued by a number of groups, 

including the NVAC in 1990, 1994, 1997 

and 2004; the Institute of Medicine; a 

2010 collaboration in between Trust for 

America’s Health, the Infectious 

Diseases Society of America, and the 

Robert Wood Johnson Foundation; the 

2007 National Immunization Congress; 

as well as by other groups of 

independent experts in the field 

working with Federal agencies. Despite 

these prior efforts, previous reports and 

recommendations have not resulted in 

sufficient improvements in the current 

status of adult immunization in the U.S. 

Additionally, recent research has helped 

to better identify additional barriers to 

adult immunization, and lessons 

learned from recent public health 

experiences—such as the 2009–10 H1N1 

pandemic—make clear the need for 

public health infrastructure for adult 

vaccines. Prior recommendations have 

provided the AIWG with examples of 

successes and opportunities for 

improvement. 

In 2009, the NVAC issued a report 

directed to Federal agencies’ adult 

immunization programs (http:// 

www.hhs.gov/nvpo/nvac/subgroups/

nvacadultimmunizations

workinggroupjune2009). The current 

draft report represents the work of the 

NVAC on phase two of this process, a 

broad examination of the national adult 

immunization program in accordance 

with the charge ‘‘to develop 

recommendations for establishing a 

comprehensive, sustainable, national 

adult immunization program that will 

lead to vaccine-preventable disease 

reduction by improving adult 

immunization coverage levels.’’ The 

NVAC includes representatives from 

public health practitioners, medical 

providers, health plan payers, 

consumers, vaccine manufacturers, and 

HHS agencies. Through review of 

previous recommendations to improve 

adult immunization, a comprehensive 

literature review of barriers to adult 

immunization, and identification of 

gaps in the current adult vaccination 

and immunization system, the AIWG 

developed draft recommendations to 

achieve the charge as noted above. 

The draft report describes the vaccinepreventable disease burden among 

adults, the current state of the adult 

immunization infrastructure, barriers to 

adult immunization, and the 

conclusions of the AIWG from these 

findings. From these conclusions, the 

AIWG makes 3 recommendations: (1) 

That there be national leadership for an 

adult immunization program, (2) That 

there be resources allocated for a 

national adult immunization program 

and action plan implementation, and (3) 

That a national strategic plan be 

developed for adult immunization. The 

report also provides recommended 

components of a national adult 

immunization program to be included 

in an action plan that fall under 5 

categories: General infrastructure, 

access, provider- or system-based 

interventions, increasing community 

demand, and research needs. 

The final revision of this report will 

be shared with the NVAC for their 

deliberation and decision for adoption. 

Should the NVAC decide to adopt these 

recommendations, the report will then 

become a report of the NVAC to the 

Assistant Secretary for Health. 

Dated: March 1, 2011. 

Bruce Gellin, 

Director, National Vaccine Program Office. 

[FR Doc. 2011–4879 Filed 3–3–11; 8:45 am] 

BILLING CODE 4150–44–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60-Day–11–0591] 

Proposed Data Collections Submitted 

for Public Comment and 

Recommendations 

In compliance with the requirement 

of Section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995 for 

opportunity for public comment on 

proposed data collection projects, the 

Centers for Disease Control and 

Prevention (CDC) will publish periodic 

summaries of proposed projects. 

Alternatively, to obtain a copy of the 

data collection plans and instrument, 

call 404–639–4773 and send comments 

to Carol E. Walker, CDC Acting Reports 

Clearance Officer, 1600 Clifton Road 

NE., MS–D74, Atlanta, Georgia 30333; 

comments may also be sent by e-mail to 

omb@cdc.gov. 

Comments are invited on (a) Whether 

the proposed collection of information 

is necessary for the proper performance 

of the functions of the agency, including 

whether the information shall have a 

practical utility; (b) the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information; (c) 

ways to enhance the quality, utility, and 

clarify of the information to be 

collected; and (d) ways to minimize the 

burden of the collection of information 

on respondents, including through the 

use of information technology. Written 

comments should be received within 60 

days of this notice. 

Proposed Project 

Select Agent Distribution Activity: 

Request for Select Agent (OMB Control 

No. 0920–0591 exp. 2/28/2011)— 

Reinstatement without change— 

National Center for Emerging and 

Zoonotic Infectious Diseases (NCEZID), 

Centers for Disease Control and 

Prevention (CDC), officially established 

as a substructure on July 9, 2010. 

Background and Brief Description 

The Centers for Disease Control and 

Prevention is requesting a three year 

extension to continue data collection 

under the Select Agent Distribution 

Activity. The form used for this activity 

is currently approved under OMB 

Control No. 0920–0591. The purpose of 

this data collection is to provide a 

systematic and consistent mechanism to 

review requests that come to CDC for 

Select Agents. The term select agents is 

used to describe a limited group of 

viruses, bacteria, rickettsia, and toxins 


jlentini on DSKJ8SOYB1PROD with NOTICES
Federal Register / Vol. 76, No. 43 / Friday, March 4, 2011 / Notices 12119 

that have the potential for use as agents 

of bioterrorism, inflicting significant 

morbidity and mortality on susceptible 

populations. 

In light of current terrorism concerns 

and the significant NIH grant monies 

directed toward Select Agent research, 

CDC receives hundreds of requests for 

Select Agents from researchers. The 

approximately 900 applicants are 

required to complete an application 

form in which they identify themselves 

and their institution, provide a 

Curriculum Vitae or biographical 

sketch, a summary of their research 

proposal, and sign indemnification and 

material transfer agreement statements. 

In this request, CDC is requesting 

approval for approximately 450 hours; 

no change from the currently approved 

burden. The only correction to this data 

collection request is updating the name 

of the National Center on the 

application form. A user fee will be 

collected to recover costs for materials, 

handling and shipping (except for 

public health laboratories). The cost to 

the respondent will vary based on 

which agent is requested. 

ESTIMATE OF ANNUALIZED BURDEN HOURS

Respondent Number of respondents 

Number of responses per 

respondent 

Average burden per response 

(in hours) 

Total burden 

(in hours) 

Researcher ...................................................................................................... 900 1 30/60 450

Total .......................................................................................................... ........................ ........................ ........................ 450 

Dated: February 25, 2011. 

Carol E. Walker, 

Acting Reports Clearance Officer, Centers for 

Disease Control and Prevention. 

[FR Doc. 2011–4948 Filed 3–3–11; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30-Day–11–0666] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

The Centers for Disease Control and 

Prevention (CDC) publishes a list of 

information collection requests under 

review by the Office of Management and 

Budget (OMB) in compliance with the 

Paperwork Reduction Act (44 U.S.C. 

Chapter 35). To request a copy of these 

requests, call the CDC Reports Clearance 

Officer at (404) 639–5960 or send an email to omb@cdc.gov. Send written 

comments to CDC Desk Officer, Office of 

Management and Budget, Washington, 

DC or by fax to (202) 395–5806. Written 

comments should be received within 30 

days of this notice. 

Proposed Project 

National Healthcare Safety Network 

(NHSN) (OMB No. 0920–0666 exp. 

3/31/2012)—Revision—National Center 

for Emerging and Zoonotic Infectious 

Diseases (NCEZID), Centers for Disease 

Control and Prevention (CDC). 

Background and Brief Description 

The National Healthcare Safety 

Network (NHSN) is a system designed to 

accumulate, exchange, and integrate 

relevant information and resources 

among private and public stakeholders 

to support local and national efforts to 

protect patients and to promote 

healthcare safety. Specifically, the data 

is used to determine the magnitude of 

various healthcare-associated adverse 

events and trends in the rates of these 

events among patients and healthcare 

workers with similar risks. Healthcare 

institutions that participate in NHSN 

voluntarily report their data to CDC 

using a web browser based technology 

for data entry and data management. 

Data are collected by trained 

surveillance personnel using written 

standardized protocols. The data will be 

used to detect changes in the 

epidemiology of adverse events 

resulting from new and current medical 

therapies and changing risks. 

This revision submission includes an 

amended Assurance of Confidentiality, 

which required an update of the 

Assurance of Confidentiality language 

on all forms included in the NHSN 

surveillance system. The scope of NHSN 

dialysis surveillance is being expanded 

to include all outpatient dialysis centers 

so that the existing Dialysis Annual 

Survey can be used to facilitate 

prevention objectives set forth in the 

HHS HAI tier 2 Action Plan and to 

assess national practices in all 

Medicare-certified dialysis centers if 

CMS re-establishes this survey method 

(as expected). The Patient Safety (PS) 

Component is being expanded to 

include long term care facilities to 

facilitate HAI surveillance in this 

setting, for which no standardized 

reporting methodology or mechanism 

currently exists. Four new forms are 

proposed for this purpose. A new form 

is proposed to be added to the 

Healthcare Personnel Safety (HPS) 

Component to facilitate summary 

reporting of influenza vaccination in 

healthcare workers, which is anticipated 

to be required by CMS in the near 

future. In addition to this new form, the 

scope of the HPS Annual Facility 

Survey is being expanded to include all 

acute care facilities that would enroll if 

CMS does implement this requirement. 

The NHSN Antimicrobial Use and 

Resistance module is transitioning from 

manual web entry to electronic data 

upload only, which results in a 

significant decrease to the reporting 

burden for this package. Finally, there 

are many updates, clarifications, and 

data collection revisions proposed in 

this submission. 

CDC is requesting to delete four 

currently approved forms that are no 

longer needed by the NHSN and add 

five new forms 

The previously-approved NHSN 

package included 47 individual data 

collection forms. If all proposed 

revisions are approved, the reporting 

burden will decrease by 1,258,119 

hours, for a total estimated burden of 

3,914,125 hours and 48 total data 

collection tools. 

Participating institutions must have a 

computer capable of supporting an 

Internet service provider (ISP) and 

access to an ISP. There is no cost to 

respondents other than their time. The 

total estimated annual burden hours are 

3,914,125. 


jlentini on DSKJ8SOYB1PROD with NOTICES